Recent Posts

News, award
Congenica is Joint Winner of MIT Solve The Horizon Prize
Posted 20th September 2021

Congenica is Joint Winner of MIT Solve The Horizon Prize

Read More
News , Blog , RareDiseases
Congenica announced as a finalist for MIT Solve’s Horizon Prize
Posted 16th September 2021

Congenica announced as a finalist for MIT Solve’s Horizon Prize

Read More
News , Product , genomics , partners
Congenica signs distribution agreement with ATC Healthcare in Turkey
Posted 19th August 2021

Congenica signs distribution agreement with ATC Healthcare in Turkey

Read More
News , Investor , Product
Congenica Receives CE Mark for Genomic Analysis Software
Posted 21st July 2021

Congenica Receives CE Mark for Genomic Analysis Software

Read More
News , Blog , genomics
David Atkins welcomes the Government
Posted 7th July 2021

David Atkins welcomes the Government's Life Sciences Sector Vision

Read More
News , Investor
Clinical OMICs interview with David Atkins CEO Congenica
Posted 25th June 2021

Clinical OMICs interview with David Atkins CEO Congenica

Read More
News , Investor
Congenica funded to reduce fatal drug interactions by mapping genes
Posted 17th June 2021

Congenica funded to reduce fatal drug interactions by mapping genes

Read More
News , genomics
Congenica named in UK’s Digital Health Playbook - ‘First 100’ Companies
Posted 27th May 2021

Congenica named in UK’s Digital Health Playbook - ‘First 100’ Companies

Read More
News , genomics
Genome UK implementation plan
Posted 24th May 2021

Genome UK implementation plan

Read More
News , Product
Congenica 3.1 - Automating best practices in variant interpretation
Posted 12th May 2021

Congenica 3.1 - Automating best practices in variant interpretation

Read More
News
Congenica assures the clinical safety of NHS genomic analysis
Posted 19th April 2021

Congenica assures the clinical safety of NHS genomic analysis

Read More
1 2 3 4 5
... 10 next
News , award
Congenica is Joint Winner of MIT Solve The Horizon Prize
Posted 20th September 2021

Congenica is Joint Winner of MIT Solve The Horizon Prize

Read More
News , Blog , RareDiseases
Congenica announced as a finalist for MIT Solve’s Horizon Prize
Posted September Sep 16th 2021

Congenica announced as a finalist for MIT Solve’s Horizon Prize

Read More
News , Product , genomics , partners
Congenica signs distribution agreement with ATC Healthcare in Turkey
Posted August Aug 19th 2021

Congenica signs distribution agreement with ATC Healthcare in Turkey

Read More
News , Investor , Product
Congenica Receives CE Mark for Genomic Analysis Software
Posted July Jul 21st 2021

Congenica Receives CE Mark for Genomic Analysis Software

Read More
News , Blog , genomics
David Atkins welcomes the Government
Posted July Jul 7th 2021

David Atkins welcomes the Government's Life Sciences Sector Vision

Read More
News , Investor
Clinical OMICs interview with David Atkins CEO Congenica
Posted June Jun 25th 2021

Clinical OMICs interview with David Atkins CEO Congenica

Read More
News , Investor
Congenica funded to reduce fatal drug interactions by mapping genes
Posted June Jun 17th 2021

Congenica funded to reduce fatal drug interactions by mapping genes

Read More
News , genomics
Congenica named in UK’s Digital Health Playbook - ‘First 100’ Companies
Posted May May 27th 2021

Congenica named in UK’s Digital Health Playbook - ‘First 100’ Companies

Read More
News , genomics
Genome UK implementation plan
Posted May May 24th 2021

Genome UK implementation plan

Read More
News , Product
Congenica 3.1 - Automating best practices in variant interpretation
Posted May May 12th 2021

Congenica 3.1 - Automating best practices in variant interpretation

Read More
News
Congenica assures the clinical safety of NHS genomic analysis
Posted April Apr 19th 2021

Congenica assures the clinical safety of NHS genomic analysis

Read More
1 2 3 4 5
... 10 next
CE 60px-Conformité_Européenne - WHITE27001 RGB Tick 60x60 Congenica UL® ISO 13485:2016 A28485 HIPAA Compliance

Copyright © 2021 Congenica Ltd. Company number: 8273616 Registered in England and Wales

Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory.